# FDA Inspection 1281734 - Danny Rischin, MBBS, FRACP, MD - August 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/danny-rischin-mbbs-fracp-md/c9712abd-04d3-43d3-990e-64c753de5c60
Source feed: FDA_Inspections

> FDA Inspection 1281734 for Danny Rischin, MBBS, FRACP, MD on August 22, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281734
- Company Name: Danny Rischin, MBBS, FRACP, MD
- Inspection Date: 2025-08-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281734 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/danny-rischin-mbbs-fracp-md/c65168ed-2682-4b18-9281-22a7c9140267)

Company: https://www.keypedia.com/companies/danny-rischin-mbbs-fracp-md/6fe55dea-b7e1-4cfa-8932-3e78386fe184

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c